Одну секунду
Что-то сучилось. Попробуйте еще раз.
Cancer research смотреть последние обновления за сегодня на .
Nearly two decades ago, researcher James Allison found a way to use the body’s own immune system to kill malignant cells, a discovery that’s transforming cancer treatment and saving lives. Photo: Michael Stravato for The Wall Street Journal Subscribe to the WSJ channel here: 🤍 Visit the WSJ channel for more video: 🤍 More from the Wall Street Journal: Visit WSJ.com: 🤍 Follow WSJ on Facebook: 🤍 Follow WSJ on Google+: 🤍 Follow WSJ on Twitter: 🤍 Follow WSJ on Instagram: 🤍 Follow WSJ on Pinterest: 🤍 Follow WSJ on Tumblr: 🤍 Don’t miss a WSJ video, subscribe here: 🤍 More from the Wall Street Journal: Visit WSJ.com: 🤍 Visit the WSJ Video Center: 🤍 On Facebook: 🤍 On Twitter: 🤍 On Snapchat: 🤍
"Targeting RAS: The Past, Present, and the Future," presented by David Hong, MD. David Hong has been a key driver in establishing one of the most innovative and influential cancer-targeted phase I clinical trial units in the world at the University of Texas MD Anderson Cancer Center. He is a world leader in conducting early-phase clinical trials of kinase inhibitors and RAS inhibitors in cancer, many of which have led to FDA approval and changes in the standard of care. #kras Breakthroughs in Cancer seminar series is one of the highest-profile seminar series for translational and clinical scientists in oncology. The series brings national leaders in cancer research to Stanford’s campus and highlights innovations across the spectrum of basic, translational, clinical, and population science. The series will be held in person on the second Tuesday of each month at Munzer Auditorium. #oncology #cancerresearch #sciencemedicine Learn more about our Breakthroughs in Cancer seminar series: 🤍 Learn more about the Stanford Cancer Institute: 🤍 Follow the Stanford Cancer Institute LinkedIn: 🤍 Twitter: 🤍 Subscribe to the Stanford Cancer Institute: 🤍
In the last 50 years, we’ve helped double cancer survival in the UK. From developing technologies like radiotherapy to leading the way in new research areas such as personalised treatment, the relentless work of our research teams changes lives. Our scientific breakthroughs mean every day, people are diagnosed earlier, have access to kinder and more effective treatments, and some cancers are prevented completely. Most importantly, it means that more people can experience those special life moments. Donate now, and help fund life-saving research: 🤍 Together we are beating cancer. Our website: 🤍 Subscribe: 🤍 Facebook: 🤍 Twitter: 🤍 Instagram: 🤍
At the Koch Institute for Integrative Cancer Research, scientists and engineers work come together to solve some of the most difficult problems in cancer. We ask big questions in strategic areas, where the answers have big impacts on how we understand and treat cancer. Through extensive collaboration with academic, clinical, and industry partners, we make sure that discoveries and innovations made in our laboratories are translated as rapidly as possible into tools and treatments that improve patient survival and quality of life.
Doctors and engineers from Massachusetts General Hospital and MIT are trying to revolutionize cancer detection through an artificial intelligence program called Sybil. Their study found that Sybil could accurately predict whether a person will develop lung cancer in the next year up to 94 percent of the time. NBC News’ Dr. John Torres reports. » Subscribe to NBC News: 🤍 » Watch more NBC video: 🤍 NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows. Connect with NBC News Online! NBC News App: 🤍 Breaking News Alerts: 🤍 Visit NBCNews.Com: 🤍 Find NBC News on Facebook: 🤍 Follow NBC News on Twitter: 🤍 Get more of NBC News delivered to your inbox: nbcnews.com/newsletters #NBCNews #AI #Cancer
At Cancer Research UK, we exist to beat cancer. For the past 120 years, we’ve been making discoveries that have saved countless lives. But who are we? Watch this short video to find out. Discover how our positive impact inspires and encourages wide-ranging support, and meet the people involved in our mission and progress: 🤍 Subscribe: 🤍 Facebook: 🤍 Twitter: 🤍 Instagram: 🤍
Watch Gareth share his brave story on terminal cancer. 25-year-old Gareth was in the army in 2015 when he was diagnosed with synovial sarcoma. He had his leg amputated to remove the cancer, and was able to join the Paralympic Team GB squad. But two years later, the cancer returned in his lungs and he was told his cancer is terminal. Read more on Gareth's blog: chemotionally-unstable.com Share your own #CancerRightNow: cruk.org/cancerrightnow To find more information on living with cancer visit cruk.org/about-cancer/coping Follow Cancer Research UK: Facebook: 🤍 Twitter: 🤍 Instagram: 🤍 Google+: 🤍
We're looking to train the scientific leaders of tomorrow. Join us, and answer your question. 🤍
Intel employee Bryce Olson was diagnosed with stage 4 prostate cancer. When the standard of care didn't work, Bryce turned to genomic sequencing which allowed his doctors to identify specific genetic drivers of his disease and identify specific treatments and clinical trials that were a fit for his specific cancer. This precision medicine approach helped send his cancer into remission for several years. Now that his cancer has returned, Bryce is working with the Broad Institute and other leaders in the field of advanced cancer research to use artificial intelligence powered by Intel technology to discover new, innovative solutions that can help him and millions of others like him around the world. This video was produced in partnership with Intel. Learn more about the work Intel is doing to power the future of healthcare intelligence at intel.com/healthcare For more stories profiling pioneers of science and tech innovation, subscribe to Freethink at 🤍 And follow Freethink across other platforms here: Facebook: 🤍 Twitter: 🤍 Instagram: 🤍 Website: 🤍
In 2018, we filmed Angela receiving her successful treatment results. Research is saving lives right now – donate to help more people survive: 🤍
In 2018, we filmed David getting his diagnosis for prostate cancer. Research is saving lives right now – donate to help more people survive: 🤍 For emotional and practical support with prostate cancer, please visit: 🤍
Top cancer immunologist reveals why most of her time is spent outside the lab, and why donations are key to advancing cancer research. In a conversation with UW Medicine oncologist Dr. Shaveta Vinayak, Dr. Nora Disis, associate dean of translational science at the University of Washington and the director of the Cancer Vaccine Institute highlights the power of philanthropy in fueling cancer research breakthroughs. The Cancer Vaccine Institute (CVI) at UW Medicine was established 20 years ago by Dr. Disis, known as the “Mother of Cancer Vaccines,” and is a collaboration of scientists, doctors, nurses, patients and philanthropists all working together to outsmart cancer. Dr. Disis and the team of researchers at the Cancer Vaccine Institute at UW Medicine in Seattle are developing vaccines for breast, colon, ovarian, prostate, pancreatic, sarcoma, lung and bladder cancers. Find out how your generous gift to the Cancer Vaccine Institute can help us outsmart cancer: 🤍 Learn more about the Cancer Vaccine Institute at UW Medicine: 🤍 Curious about cancer vaccine clinical trials? 🤍 Watch the full conversation with Drs. Disis and Vinayak at: 🤍 As the largest academic research group dedicated to the development of cancer vaccines, their goal is to bring the power of precision medicine and cancer immunology out of the lab and into the lives of people to treat, and ultimately prevent, cancer and its recurrence. CVI’s “multi-antigenic” vaccines target multiple proteins that appear in high levels in cancer tissue and are designed to elicit a specific type of immune system response known to be effective at killing cancer cells. These methods are unique to the CVI and set them apart from other cancer vaccine research. Researchers at the Cancer Vaccine Institute are closer than ever to making cancer a preventable, treatable condition. But they can’t do it without your generous and visionary support: 🤍
1 in 2 of us will get cancer in our lifetime. But all of us can support the research that will beat it. Everyone has a part to play and every part supports life-saving research. So play your part, and together we will beat cancer. Find out how to play your part: 🤍 Visit our About Cancer pages: 🤍 For information and support: 🤍 Our shops: 🤍 Join the Race for Life: 🤍 Leave a gift in your will: 🤍
1 in 2 of us will get cancer in our lifetime. All of us can support the research that will beat it. Everyone has a part to play, and every part supports life-saving research. Donate now and together we will beat cancer: 🤍 Subscribe: 🤍 Facebook: 🤍 Twitter: 🤍 Instagram: 🤍
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. 🤍 Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.
We've produced an inspiring new film which brings our brand manifesto to life through a collection of powerful images and stories. Capturing our collective spirit and determination to save more lives, it shows our belief that our science holds the solution to beating cancer and demonstrates the role that every pound, every hour, and every person plays in helping us make that day come sooner.
We're funding world-class researchers to unlock more answers to cancer.
Breast cancer is one of the most diagnosed cancers among women, with an estimated 2.1 million new cases of breast cancer globally each year. Immunotherapy for breast cancer is developing rapidly following the first FDA-approved checkpoint inhibitor for triple-negative breast cancer in March 2019. New treatment regimens combining immunotherapy with chemotherapy, radiation, or surgery are showing promise in clinical trials. Dr. Elizabeth Mittendorf of Dana-Farber/Harvard Cancer Center will answer your questions and discuss current immunotherapy research for breast cancer.
Radiotherapy plays a crucial part in treating lots of different cancers. And new technology is making it more precise and reducing side effects. It works by firing x-rays or other intense bundles of energy at cancer cells, damaging their DNA. If a cancer cell can't repair its damaged DNA, it dies. 0:01 Radiotherapy 0:20 What does the radiation do? 0:30 How does radiotherapy work? 1:04 SABR - a new technique 1:24 Proton beam therapy 1:42 Thyroid cancer treatment Find out more about radiotherapy on the Cancer Research UK news website: 🤍 Subscribe: youtube.com/user/cancerresearchuk Facebook: facebook.com/cancerresearchuk Twitter: twitter.com/CR_UK Instagram: instagram.com/cr_uk
Tackling all cancers We want survival in the UK to be among the best in the world. We’re focusing our efforts in four key areas – working to help prevent cancer, diagnose it earlier, develop new treatments and optimise current treatments by personalising them and making them even more effective. We’ll continue to support research into all types of cancer and across all age groups. And we’re keeping our focus on understanding the biology of cancer so we can use this vital knowledge to save more lives. We’re increasing our research in key areas such as early diagnosis, and hard-to-treat cancers including lung, pancreatic, oesophageal cancers and brain tumours. We’re developing new tests, surgery and radiotherapy techniques, and cancer drugs. We want to personalise prevention, screening and treatment and bring benefits to patients sooner. To help accelerate progress, we’ll be investing an additional £50 million a year into new funding schemes for our researchers. These will encourage collaboration and innovation, and support research tackling some of the biggest scientific challenges in cancer research. Watch our film to find out more and visit: 🤍 Let's beat cancer sooner.
Researchers are taking a new approach and using genetic testing to unlock causes and potential treatments for certain cancers.
Immunotherapy is transforming cancer treatment and care today—and shows even greater promise for the future. Discover how this innovative treatment works across several cancer types both alone and in combination with other treatments. Dr. Jen Wargo of MD Anderson Cancer Center will explore how our immune system works, break down into basic concepts the complex science underlying immunotherapy, describe the different types of immunotherapy, and discuss potential side effects and benefits patients can anticipate. After the presentation, ask your questions during a live Q&A moderated by Tamron Hall.
Pledge right now to leave a gift in your Will to Cancer Research UK and together we will beat cancer for future generations. To find out more, please visit: 🤍 Gifts in Wills make an impact Gifts in Wills fund over a third of Cancer Research UK’s life saving research. They've helped double survival rates in the last 40 years. They enable long term research projects that lead to new treatments and cures. Leaving a legacy gift in your Will makes a real difference to one day beating cancer.
🤍 For the first time, as many people survive cancer as die from cancer. But we know that’s not good enough. We need to keep pushing. Keep striving. Keep fighting. So that one day, everyone will survive cancer. We will beat cancer sooner. Join the fight at cruk.org
There has been a crucial breakthrough in the fight against the cancer. A trial was carried out at a cancer center in New York. Patients were injected with a drug, and after 6 months, cancer tumors vanished in all patients. #Cancercure #Cancerpatient #WION About Channel: WION -The World is One News, examines global issues with in-depth analysis. We provide much more than the news of the day. Our aim to empower people to explore their world. With our Global headquarters in New Delhi, we bring you news on the hour, by the hour. We deliver information that is not biased. We are journalists who are neutral to the core and non-partisan when it comes to the politics of the world. People are tired of biased reportage and we stand for a globalised united world. So for us the World is truly One. Please keep discussions on this channel clean and respectful and refrain from using racist or sexist slurs as well as personal insults. Subscribe to our channel at 🤍 Check out our website: 🤍 Connect with us on our social media handles: Facebook: 🤍 Twitter: 🤍 Follow us on Google News for latest updates Zee News:- 🤍 Zee Bussiness:- 🤍 DNA India:- 🤍 WION: 🤍 Zee News Apps : 🤍
"Tumor Intrinsic Features of Immunity," presented Luis Diaz, MD. Luis Diaz, MD, is a renowned medical oncologist and translational scientist who is the head of solid tumor oncology at Memorial Sloan Kettering Cancer Center. His influential work in immuno-oncology led to the approval of checkpoint inhibitors for cancers that are deficient in the mismatch repair pathway, regardless of tissue of origin. He is also a leader in the application of circulating tumor DNA for cancer diagnosis and for the monitoring of therapeutic resistance. He is a member of President Biden’s National Cancer Advisory Board, a Fellow of the AACR Academy and a recipient of the Giants of Cancer Care award. Breakthroughs in Cancer seminar series is one of the highest-profile seminar series for translational and clinical scientists in oncology. The series brings national leaders in cancer research to Stanford’s campus and highlights innovations across the spectrum of basic, translational, clinical, and population science. The series will be held in person on the second Tuesday of each month at Munzer Auditorium. #oncology #cancerresearch #sciencemedicine Learn more about our Breakthroughs in Cancer seminar series: 🤍 Learn more about the Stanford Cancer Institute: 🤍 Follow the Stanford Cancer Institute LinkedIn: 🤍 Twitter: 🤍 Subscribe to the Stanford Cancer Institute: 🤍
The NHS has announced changes in cancer waiting times in England, including a shift to the Faster Diagnosis Standard. This will help set clearer expectations for people about the timeline by when they should receive a diagnosis of cancer, or be given the all-clear, following an urgent referral. Read more in our article: 🤍 #FasterDiagnosisStandard #CancerWaitingTimes #CancerInformation #HealthInformation Subscribe: 🤍 Facebook: 🤍 Twitter: 🤍 Instagram: 🤍
Throughout the past twenty years, Cancer Cell has become a destination for advances that push the boundaries of cancer research and pave the way for exciting new therapies.
Bowel cancer is a broad term for cancer that begins in the large bowel, which is made up of the colon and rectum. Find out about the possible symptoms of bowel cancer. Go and see your doctor if you have any of these symptoms or you have anything that is not normal for you. Remember there are other conditions much less serious than cancer that can cause these symptoms. Find out more: 🤍 Subscribe: 🤍 Facebook: 🤍 Twitter: 🤍 Instagram: 🤍
NBC News got exclusive access to the Los Alamos National Laboratory where physicists are manufacturing a radioactive procedure that could possibly revolutionize cancer treatment. » Subscribe to NBC News: 🤍 » Watch more NBC video: 🤍 NBC News is a leading source of global news and information. Here you will find clips from NBC Nightly News, Meet The Press, and our original series Debunker, Flashback, Nerdwatch, and Show Me. Subscribe to our channel for news stories, technology, politics, health, entertainment, science, business, and exclusive NBC investigations. Connect with NBC News Online! Visit NBCNews.Com: 🤍 Find NBC News on Facebook: 🤍 Follow NBC News on Twitter: 🤍 Follow NBC News on Google+: 🤍 Follow NBC News on Instagram: 🤍 Follow NBC News on Pinterest: 🤍 Inside the Top-Secret Nuclear Lab at Forefront of Cancer Research | NBC Nightly News
We can cure cancer by spotting it sooner. Who do you talk to about changes to your body that hang around for a while? It doesn't matter who you discuss them with, as long as you also talk to your doctor. Watch our video to find out more. Find out more: 🤍
MD Anderson Cancer Center is home to the brightest minds in research, who are driving breakthroughs that transform the field, the lives of patients and society. Research opportunities exist across the cancer spectrum, including prevention, patient care and survivorship. From basic discoveries to impacts in the clinic and back to the lab, our scientists and clinicians work seamlessly together to follow a hypothesis, test new theories and deliver breakthroughs at unmatched speeds. Learn more: MDAnderson.org/Research Request an appointment at MD Anderson by calling 1-877-632-6789 or online: 🤍
I’m Farah Alam, a second year PhD student at the UCL GOS Institute of Child Health in the Developmental Biology and Cancer Section. My PhD is focused on investigating how radiotherapy can be used to improve efficacy of an experimental immunotherapy, known as CAR-T cells in solid cancers. I’m mostly based at the ZCR building of ICH, and I’m an entirely wet lab student, so most of the day is spent on conducting experiments that involves a range of different laboratory techniques. I also balance the experimental work with meetings, journal clubs, and other aspects of admin work that involves a PhD. Outside of my PhD, I tend to spend most of my time reading books and attempting to learn how to crotchet and knit (which is way harder than I thought it would be!). Find out more about our PhD programme here - 🤍 Video produced by Jasmin Rees, Farah Alam and Tahmina Aktar.
Early-career researcher Andreana Holowatyj, PhD, is a committed science advocate. Her research focuses on understanding why people younger than 50 are being diagnosed with colorectal cancer at a growing rate.
Research takes months of ideas, testing, trialling, and learning… But months of research need monthly donations. Donate monthly and together we will beat cancer. Donate: 🤍 Subscribe: 🤍 Facebook: 🤍 Twitter: 🤍 Instagram: 🤍
When she’s not studying to be a doctor or in the lab working on cancer-killing viruses, Métis researcher Taylor Jamieson-Datzkiw can be found mentoring the next generation of scientists and health-care providers. “Every day as I walk through the Cancer Centre I see people who look sick, and who need more options, and that’s what really motivates me.”
The SCI is focused on pushing the limits of what we can do and what we know. The only way to really advance our knowledge is to push forward in laboratories, keep thinking about novel approaches, novel mechanisms. We cannot stand still. #cancer #science #research Learn more about the Stanford Cancer Institute: 🤍 Follow the Stanford Cancer Institute: LinkedIn: 🤍 Twitter: 🤍 Subscribe to the Stanford Cancer Institute: 🤍
Cait is currently receiving treatment for lung cancer. Having started treatment with chemotherapy, Cait was then treated with radiotherapy before starting a new immunotherapy drug. Watch as Cait shares her cancer treatment experience. You can find out more on lung cancer on our website: 🤍
When people think of the progress made in cancer research, they don’t often realize the harmony that must take place to make scientific discovery possible. Within the NCI Cancer Research Data Commons (CRDC), a single cloud-based infrastructure, cancer researchers can work in concert to access, analyze, share, and store a variety of data without the downtime of downloading. The CRDC allows researchers to perform cross-domain analysis of large data sets that can lead to new discoveries in cancer prevention, treatment, and diagnosis. 🤍 🤍
Help beat cancer by taking on a run, swim or cycle and fundraising along the way. From marathons to triathons, there's something for everyone
.svg){kind=small}
